Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Chromatin CEO to Address BIO 2004 on New Science Driving Agricultural Biotechnology.


Business Editors/Science Writers/Health/Medical Writers

BIO 2004 Annual Convention

BIOWIRE2K

CHICAGO--(BUSINESS WIRE)--June 4, 2004

Chromatin chromatin: see chromosome.  Inc. announced today that Mich Hein, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , will speak on a panel at BIO 2004 discussing new scientific knowledge that will drive the agricultural biotechnology business.

The panel, titled "Hot Topics Track: Food and Agriculture," will be held at BIO in San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden  on Wed., June 9, at 9:30 a.m.

The session will cover: the ability to stack genes efficiently in crop plants, novel ways of utilizing plant cell biology Cell biology

The study of the activities, functions, properties, and structures of cells. Cells were discovered in the middle of the seventeenth century after the microscope was invented.
 to develop new products and applications, and the utilization of biotechnology in novel areas such as aquaculture aquaculture, the raising and harvesting of fresh- and saltwater plants and animals. The most economically important form of aquaculture is fish farming, an industry that accounts for an ever increasing share of world fisheries production. .

"This session will showcase some of the hottest scientific discoveries and applications in food and agricultural biotechnology," according to according to
prep.
1. As stated or indicated by; on the authority of: according to historians.

2. In keeping with: according to instructions.

3.
 the BIO 2004 program.

About Chromatin

Chromatin Inc., develops and markets novel proprietary technology that enables entire chromosomes to be designed and incorporated into plant cells. These engineered chromosomes make it possible for the first time to simultaneously introduce multiple genes into a plant cell while maintaining precise control of gene expression. Chromatin is employing these new genetic tools to design and market products that confer commercially valuable traits in plants, including improved nutritional and health characteristics, and can be used for industrial, agricultural and pharmaceutical product development. For more information go to www.chromatininc.com.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 4, 2004
Words:225
Previous Article:IVAX Acquires Peruvian Pharmaceutical Company.
Next Article:InterDigital Executives Review Strategic Objectives, Corporate Governance Enhancements, and Compensation Program at 2004 Annual Meeting of...



Related Articles
Chromatin Secures $2.7 Million in ATP/NIH Grants to Develop Mini-Chromosome Technology; Technology Overcomes Barrier to the Introduction of Multiple...
Saskatchewan is ... Biotech Central.
Illinois Biotechnology Industry Organization -iBIO- Elects New Chairman, Taps Three New Directors; Industry Veteran Bill Gantz of Ovation...
Chromatin Announces International Partnerships to Introduce Mini-Chromosomes into Canola.
Chromatin Announces Anthony J. Cavalieri, Former Pioneer Hi-Bred VP, Joins Board of Directors.
Chromatin Announces Michael Pauly Hired as Chief Scientific Officer; Former Novartis Director of Plant Breeding and Biotechnology Brings 18 Years of...
Jim Greenwood, BIO CEO Delivers Keynote Speech at MBC's Annual Meeting, Building the Global Pipeline: Massachusetts Life Sciences at Work.
Leading Illinois Bioscience and Medical Device Companies Selected to Present at BIO Mid-America VentureForum; Illinois Companies and Venture...
BIO Commends USTR for Successfully Concluding U.S.-Korea Free Trade Agreement.
Chromatin Promotes Daphne Preuss to President; Adds New Members to Board of Directors.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles